Avantor (NYSE:AVTR) Given New $26.00 Price Target at Robert W. Baird

Avantor (NYSE:AVTR) had its price objective cut by Robert W. Baird from $27.00 to $26.00 in a report released on Monday, Benzinga reports. They currently have an outperform rating on the stock.

Several other equities analysts have also recently commented on the stock. Royal Bank of Canada upped their target price on shares of Avantor from $28.00 to $29.00 and gave the company an outperform rating in a research note on Thursday, February 15th. Citigroup boosted their price target on shares of Avantor from $24.00 to $30.00 and gave the company a buy rating in a report on Thursday, February 15th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Avantor from $23.00 to $25.00 and gave the company a hold rating in a report on Thursday, April 18th. JPMorgan Chase & Co. boosted their price target on shares of Avantor from $26.00 to $29.00 and gave the company an overweight rating in a report on Thursday, February 15th. Finally, UBS Group boosted their price target on shares of Avantor from $25.00 to $29.00 and gave the company a buy rating in a report on Thursday, February 15th. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, Avantor presently has a consensus rating of Moderate Buy and an average target price of $26.71.

Avantor Price Performance

NYSE:AVTR opened at $24.32 on Monday. The stock has a market cap of $16.52 billion, a P/E ratio of 62.36, a PEG ratio of 1.47 and a beta of 1.36. Avantor has a one year low of $16.63 and a one year high of $26.16. The company has a fifty day moving average price of $25.08 and a 200 day moving average price of $22.70. The company has a debt-to-equity ratio of 0.94, a current ratio of 1.61 and a quick ratio of 1.05.

Avantor (NYSE:AVTR) last released its earnings results on Friday, April 26th. The company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.20 by $0.02. The firm had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.68 billion. Avantor had a net margin of 3.79% and a return on equity of 13.01%. The business’s quarterly revenue was down 5.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.29 EPS. Analysts anticipate that Avantor will post 1.01 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP James Bramwell sold 6,203 shares of the company’s stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $24.49, for a total transaction of $151,911.47. Following the transaction, the executive vice president now owns 101,143 shares in the company, valued at approximately $2,476,992.07. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 1.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in AVTR. Fifth Third Bancorp lifted its position in Avantor by 125.3% during the 4th quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock valued at $28,000 after purchasing an additional 694 shares during the period. Livforsakringsbolaget Skandia Omsesidigt lifted its position in Avantor by 565.5% during the 4th quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company’s stock valued at $30,000 after purchasing an additional 1,131 shares during the period. Gladius Capital Management LP acquired a new position in Avantor during the 4th quarter valued at about $42,000. Montag A & Associates Inc. acquired a new position in Avantor during the 4th quarter valued at about $43,000. Finally, TFO Wealth Partners LLC lifted its position in Avantor by 203,100.0% during the 4th quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock valued at $46,000 after purchasing an additional 2,031 shares during the period. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.